Cargando…
Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse
Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have an irreplaceable role in the treatment of myocardial infarction (MI), which can be injected into the transplanted area with new cardiomyocytes (Cardiomyocytes, CMs), and improve myocardial function. However, the immaturity of the s...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167678/ https://www.ncbi.nlm.nih.gov/pubmed/35702609 http://dx.doi.org/10.1016/j.bioactmat.2022.05.024 |
_version_ | 1784720847752134656 |
---|---|
author | Wu, Peng Sai, Xiyalatu Li, Zhetao Ye, Xing Jin, Li Liu, Guihuan Li, Ge Yang, Pingzhen Zhao, Mingyi Zhu, Shuoji Liu, Nanbo Zhu, Ping |
author_facet | Wu, Peng Sai, Xiyalatu Li, Zhetao Ye, Xing Jin, Li Liu, Guihuan Li, Ge Yang, Pingzhen Zhao, Mingyi Zhu, Shuoji Liu, Nanbo Zhu, Ping |
author_sort | Wu, Peng |
collection | PubMed |
description | Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have an irreplaceable role in the treatment of myocardial infarction (MI), which can be injected into the transplanted area with new cardiomyocytes (Cardiomyocytes, CMs), and improve myocardial function. However, the immaturity of the structure and function of iPSC-CMs is the main bottleneck at present. Since collagen participates in the formation of extracellular matrix (ECM), we synthesized nano colloidal gelatin (Gel) with collagen as the main component, and confirmed that the biomaterial has good biocompatibility and is suitable for cellular in vitro growth. Subsequently, we combined the PI3K/AKT/mTOR pathway inhibitor BEZ-235 with Gel and found that the two combined increased the sarcomere length and action potential amplitude (APA) of iPSC-CMs, and improved the Ca(2+) processing ability, the maturation of mitochondrial morphological structure and metabolic function. Not only that, Gel can also prolong the retention rate of iPSC-CMs in the myocardium and increase the expression of Cx43 and angiogenesis in the transplanted area of mature iPSC-CMs, which also provides a reliable basis for the subsequent treatment of mature iPSC-CMs. |
format | Online Article Text |
id | pubmed-9167678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | KeAi Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-91676782022-06-13 Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse Wu, Peng Sai, Xiyalatu Li, Zhetao Ye, Xing Jin, Li Liu, Guihuan Li, Ge Yang, Pingzhen Zhao, Mingyi Zhu, Shuoji Liu, Nanbo Zhu, Ping Bioact Mater Article Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have an irreplaceable role in the treatment of myocardial infarction (MI), which can be injected into the transplanted area with new cardiomyocytes (Cardiomyocytes, CMs), and improve myocardial function. However, the immaturity of the structure and function of iPSC-CMs is the main bottleneck at present. Since collagen participates in the formation of extracellular matrix (ECM), we synthesized nano colloidal gelatin (Gel) with collagen as the main component, and confirmed that the biomaterial has good biocompatibility and is suitable for cellular in vitro growth. Subsequently, we combined the PI3K/AKT/mTOR pathway inhibitor BEZ-235 with Gel and found that the two combined increased the sarcomere length and action potential amplitude (APA) of iPSC-CMs, and improved the Ca(2+) processing ability, the maturation of mitochondrial morphological structure and metabolic function. Not only that, Gel can also prolong the retention rate of iPSC-CMs in the myocardium and increase the expression of Cx43 and angiogenesis in the transplanted area of mature iPSC-CMs, which also provides a reliable basis for the subsequent treatment of mature iPSC-CMs. KeAi Publishing 2022-06-04 /pmc/articles/PMC9167678/ /pubmed/35702609 http://dx.doi.org/10.1016/j.bioactmat.2022.05.024 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Wu, Peng Sai, Xiyalatu Li, Zhetao Ye, Xing Jin, Li Liu, Guihuan Li, Ge Yang, Pingzhen Zhao, Mingyi Zhu, Shuoji Liu, Nanbo Zhu, Ping Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse |
title | Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse |
title_full | Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse |
title_fullStr | Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse |
title_full_unstemmed | Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse |
title_short | Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse |
title_sort | maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167678/ https://www.ncbi.nlm.nih.gov/pubmed/35702609 http://dx.doi.org/10.1016/j.bioactmat.2022.05.024 |
work_keys_str_mv | AT wupeng maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT saixiyalatu maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT lizhetao maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT yexing maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT jinli maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT liuguihuan maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT lige maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT yangpingzhen maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT zhaomingyi maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT zhushuoji maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT liunanbo maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse AT zhuping maturationofinducedpluripotentstemcellderivedcardiomyocytesanditstherapeuticeffectonmyocardialinfarctioninmouse |